AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AstraZeneca PLC(4.88%),AstraZeneca UK Limited(4.88%)
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.1%)
AstraZeneca | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AstraZeneca Holdings B.V.(22.4%),AstraZeneca PLC(22.4%)
AstraZeneca | SC 13D: Statement of acquisition of beneficial ownership by individuals-AstraZeneca Holdings B.V.(22.4%),AstraZeneca PLC(22.4%)
AstraZeneca | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-MedImmune Limited(3.4%),AstraZeneca PLC(3.4%)
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-AstraZeneca AB(4.8%),AstraZeneca PLC(4.8%)
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-BlackRock, Inc.(9.6%)
AstraZeneca | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(10.2%)
AstraZeneca | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.0%)
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(4.23%),Wellington Group Holdings LLP(4.23%), etc.
AstraZeneca | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
AstraZeneca | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
AstraZeneca | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
AstraZeneca | 4: Statement of changes in beneficial ownership of securities
AstraZeneca | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
AstraZeneca | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
AstraZeneca | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
AstraZeneca | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.8%)
No Data